Skip to content

Clinical trials

Terminated Phase 1 Recurrence trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Phase: Phase 1 Status: Terminated Clear all

136 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20043
20054
20071
20084
20098
20102
20112
20124
20132
201414
20158
201612
201710
20189
201911
202010
202113
20226
20237
20244
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated136

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene10
M.D. Anderson Cancer Center6
National Cancer Institute (NCI)4
University of Pennsylvania4
AbbVie3
Kite, A Gilead Company3
Novartis Pharmaceuticals3
Therapeutic Advances in Childhood Leukemia Consortium3
Amgen2
Aptose Biosciences Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence136
Leukemia, Myeloid, Acute32
Multiple Myeloma22
Neoplasms18
Neoplasm Metastasis17
Leukemia, Lymphocytic, Chronic, B-Cell15
Lymphoma, Non-Hodgkin13
Leukemia12
Precursor Cell Lymphoblastic Leukemia-Lymphoma12
Lymphoma11

Trials

Showing 1 to 25 of 136. Each trial links to its page on Pharma Observatory.

36 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.